Form 4: NEOGEN Director Andrea Wainer Boosts Stake with Share Acquisition and Derivative Grants

NEOGEN Corporation's Director, Andrea F. Wainer, acquired 6,090 shares of common stock and 16,303 derivative securities (options/RSUs) on June 2, 2025, signaling increased insider ownership.

Summary

• Andrea F. Wainer, a Director of NEOGEN Corp (NEOG), acquired 6,090 shares of the company's common stock on June 2, 2025.
• The acquisition price for the common stock was $5.69 per share.
• Ms. Wainer also received a grant of 16,303 derivative securities, identified as "Common Stock (Right to Buy)," which are options or Restricted Stock Units (RSUs), on the same date.
• These derivative securities have a conversion or exercise price of $5.69 and are set to expire on June 2, 2032.
• The options and RSUs will vest in equal annual installments on each of the first three anniversary dates of the grants.
• Following these transactions, Ms. Wainer directly beneficially owns 6,090 shares of common stock and 16,303 derivative securities.

Sentiment

Score: 7

Explanation: The acquisition of shares and grant of derivative securities to a director generally indicates confidence in the company's future prospects and aligns management's interests with shareholders, which is a positive signal.

Positives

• A director, Andrea F. Wainer, increased her direct beneficial ownership in NEOGEN Corp by acquiring 6,090 shares of common stock and 16,303 derivative securities (options/RSUs), which can be interpreted as a sign of confidence in the company's future.
• The acquisition of shares and grant of derivative securities aligns the director's financial interests more closely with those of the company's shareholders.

Future Outlook

The acquired derivative securities (options/RSUs) will vest in equal annual installments over the next three years, indicating a future increase in the director's vested equity stake and continued alignment of interests.

Industry Context

This Form 4 filing details an individual insider transaction and does not provide broader industry context or trends, focusing solely on changes in beneficial ownership for a specific director at NEOGEN Corporation.

Stakeholder Impact

• Shareholders may view the director's increased equity stake as a positive signal of confidence in the company's future performance and strategic direction.

Next Steps

• The derivative securities (options/RSUs) will vest in equal annual installments on each of the first three anniversary dates of the grants, leading to a gradual increase in the director's vested shareholdings.

Key Dates

Keywords

NEOGEN, NEOG, Form 4, Insider Transaction, Director Stock Acquisition, Stock Options, Restricted Stock Units, Beneficial Ownership, Corporate Governance